Literature DB >> 30867316

Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages.

Olivier Leymarie1,2,3, Leslie Lepont1,2,3, Margaux Versapuech1,2,3, Delphine Judith1,2,3, Sophie Abelanet1,2,3, Katy Janvier1,2,3, Clarisse Berlioz-Torrent4,2,3.   

Abstract

HIV-1 infection of macrophages leads to the sequestration of newly formed viruses in intracellular plasma membrane-connected structures termed virus-containing compartments (VCCs), where virions remain infectious and hidden from immune surveillance. The cellular restriction factor bone marrow stromal cell antigen 2 (BST2), which prevents HIV-1 dissemination by tethering budding viral particles at the plasma membrane, can be found in VCCs. The HIV-1 accessory protein Vpu counteracts the restriction factor BST2 by downregulating its expression and removing it from viral budding sites. Numerous studies described these Vpu countermeasures in CD4+ T cells or model cell lines, but the interplay between Vpu and BST2 in VCC formation and HIV-1 production in macrophages is less explored. Here, we show that Vpu expression in HIV-1-infected macrophages enhances viral release. This effect is related to Vpu's ability to circumvent BST2 antiviral activity. We show that in absence of Vpu, BST2 is enriched in VCCs and colocalizes with capsid p24, whereas Vpu expression significantly reduces the presence of BST2 in these compartments. Furthermore, our data reveal that BST2 is dispensable for the formation of VCCs and that Vpu expression impacts the volume of these compartments. This Vpu activity partly depends on BST2 expression and requires the integrity of the Vpu transmembrane domain, the dileucine-like motif E59XXXLV64 and phosphoserines 52 and 56 of Vpu. Altogether, these results highlight that Vpu controls the volume of VCCs and promotes HIV-1 release from infected macrophages.IMPORTANCE HIV-1 infection of macrophages leads to the sequestration of newly formed viruses in virus-containing compartments (VCCs), where virions remain infectious and hidden from immune surveillance. The restriction factor BST2, which prevents HIV-1 dissemination by tethering budding viral particles, can be found in VCCs. The HIV-1 Vpu protein counteracts BST2. This study explores the interplay between Vpu and BST2 in the viral protein functions on HIV-1 release and viral particle sequestration in VCCs in macrophages. The results show that Vpu controls the volume of VCCs and favors viral particle release. These Vpu functions partly depend on Vpu's ability to antagonize BST2. This study highlights that the transmembrane domain of Vpu and two motifs of the Vpu cytoplasmic domain are required for these functions. These motifs were notably involved in the control of the volume of VCCs by Vpu but were dispensable for the prevention of the specific accumulation of BST2 in these structures.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  BST2/tetherin; VCC; Vpu; human immunodeficiency virus; macrophage; restriction factor; vesicular trafficking; viral release

Mesh:

Substances:

Year:  2019        PMID: 30867316      PMCID: PMC6532093          DOI: 10.1128/JVI.00020-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

Review 1.  Macrophage activation and HIV infection: can the Trojan horse turn into a fortress?

Authors:  G Herbein; A Coaquette; D Perez-Bercoff; G Pancino
Journal:  Curr Mol Med       Date:  2002-12       Impact factor: 2.222

Review 2.  Retroviral spread by induction of virological synapses.

Authors:  Clare Jolly; Quentin J Sattentau
Journal:  Traffic       Date:  2004-09       Impact factor: 6.215

3.  Macrophages archive HIV-1 virions for dissemination in trans.

Authors:  Natalia Sharova; Catherine Swingler; Mark Sharkey; Mario Stevenson
Journal:  EMBO J       Date:  2005-05-26       Impact factor: 11.598

Review 4.  Lipid rafts and HIV-1: from viral entry to assembly of progeny virions.

Authors:  S M Campbell; S M Crowe; J Mak
Journal:  J Clin Virol       Date:  2001-10       Impact factor: 3.168

5.  Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus.

Authors:  Stefano Aquaro; Patrizia Bagnarelli; Tania Guenci; Andrea De Luca; Massimo Clementi; Emanuela Balestra; Raffaele Caliò; Carlo-Federico Perno
Journal:  J Med Virol       Date:  2002-12       Impact factor: 2.327

6.  Human macrophages accumulate HIV-1 particles in MHC II compartments.

Authors:  Graça Raposo; Marilyn Moore; Donald Innes; Richtje Leijendekker; Andrew Leigh-Brown; Philippe Benaroch; Hans Geuze
Journal:  Traffic       Date:  2002-10       Impact factor: 6.215

7.  Plasma membrane is the site of productive HIV-1 particle assembly.

Authors:  Nolwenn Jouvenet; Stuart J D Neil; Cameron Bess; Marc C Johnson; Cesar A Virgen; Sanford M Simon; Paul D Bieniasz
Journal:  PLoS Biol       Date:  2006-12       Impact factor: 8.029

8.  HIV-1 buds predominantly at the plasma membrane of primary human macrophages.

Authors:  Sonja Welsch; Oliver T Keppler; Anja Habermann; Ina Allespach; Jacomine Krijnse-Locker; Hans-Georg Kräusslich
Journal:  PLoS Pathog       Date:  2007-03       Impact factor: 6.823

Review 9.  Electron microscopy analysis of viral morphogenesis.

Authors:  Annegret Pelchen-Matthews; Mark Marsh
Journal:  Methods Cell Biol       Date:  2007       Impact factor: 1.441

10.  Infectious HIV-1 assembles in late endosomes in primary macrophages.

Authors:  Annegret Pelchen-Matthews; Beatrice Kramer; Mark Marsh
Journal:  J Cell Biol       Date:  2003-07-28       Impact factor: 10.539

View more
  3 in total

Review 1.  Plasma Membrane-Associated Restriction Factors and Their Counteraction by HIV-1 Accessory Proteins.

Authors:  Peter W Ramirez; Shilpi Sharma; Rajendra Singh; Charlotte A Stoneham; Thomas Vollbrecht; John Guatelli
Journal:  Cells       Date:  2019-09-02       Impact factor: 6.600

2.  S100A8-mediated metabolic adaptation controls HIV-1 persistence in macrophages in vivo.

Authors:  Fernando Real; Aiwei Zhu; Boxin Huang; Ania Belmellat; Alexis Sennepin; Thomas Vogl; Céline Ransy; Marc Revol; Riccardo Arrigucci; Anne Lombès; Johannes Roth; Maria Laura Gennaro; Frédéric Bouillaud; Sarra Cristofari; Morgane Bomsel
Journal:  Nat Commun       Date:  2022-10-11       Impact factor: 17.694

Review 3.  Focus on the morphogenesis, fate and the role in tumor progression of multivesicular bodies.

Authors:  Xueqiang Peng; Liang Yang; Yingbo Ma; Yan Li; Hangyu Li
Journal:  Cell Commun Signal       Date:  2020-08-08       Impact factor: 5.712

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.